• 2022-06-07
    Assuming
    that a vaccine against hepatitis C was developed. To evaluate the
    effectiveness of this vaccine, the population that should be
    selected as the research object is ( )
    A: People
    with low incidence of hepatitis C
    B: People infected with hepatitis C
    C: People
    who have been infected with hepatitis B
    D: High-risk population of hepatitis C